Depletion of MDSCs completely abolished the previously observed increase in CD8+IFN-γ+ T cell tumour infiltration as well as the therapeutic anti-tumour effect of BTNL2 blockade (Fig. 4h–j). The gene discussed is CD8A; the disease is neoplasm.